Furiex Pharmaceuticals Inc. (extinct)

Furiex Pharmaceuticals Inc. (extinct)

Furiex Pharmaceuticals Inc. (extinct)

Overview
Date Founded

1998

Headquarters

3900 Paramount Parkway, Suite 150, Morrisville, NC, 27560, USA

Type of Company

Private

Employees (Worldwide)

10K - 1M

Industries

Pharmaceuticals
IT Consulting & Services
Hospitals & Patient Services
Medical Support Services
Biotechnology

Company Description

Furiex Pharmaceuticals, Inc. is a drug development collaboration company using innovative clinical development strategies to accelerate and increase the value of partnered drug programs by advancing them through development in a cost-efficient manner. As the biopharmaceutical industry faces increased R&D spending with fewer successful therapies reaching the market, Furiex offers a new approach to help drug developers lower development costs and deliver products to the market more efficiently

Website

http://furiex.com

Contact Data
Trying to get in touch with decision makers at Furiex Pharmaceuticals Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
In The News
PR Newswire
March 26, 2018
Biotech Market Poised to Reach 2015 Highs
PR Newswire
July 13, 2017
Global Antibiotics Technologies, Markets, Competitors and Opportunities 2017-2022: The Quest for New Super Drugs
PR Newswire
February 27, 2017
BrainStorm Names Dr. June S. Almenoff and Arturo O. Araya to its Board of Directors as Company Prepares for Clinical and Commercial Success
Business Insider
March 9, 2016
Valeant names 3 new members to its board, stock rises 4% (VRX)
PR Newswire
December 8, 2015
RDD Pharma Appoints Dr. June Almenoff as Board Chairman

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.
Trending People
3M Innovative Properties Co.
3M Innovative Properties Assigned Patent for Halogen, Polyhalide Mediated Phenol... - Targeted News Service
US Defense Logistics Agency
ISSPRO Wins $250,000 Federal Contract - Targeted News Service
Pfizer, Inc.
Senior doctors attack decision to make people wait 12 weeks for second dose of P... - The Independent UK
United States Department of Veterans Affairs
ALL AMERICAN CONTRACTING SOLUTIONS Wins $24,910 Federal Contract - Targeted News Service
Atlanta Braves, Inc.
SPORTS; RIP to Hammerin' Hank: He had all of the tools - Los Angeles Times
Trending Organizations
3M Innovative Properties Co.
3M Innovative Properties Assigned Patent for Halogen, Polyhalide Mediated Phenol... - Targeted News Service
US Defense Logistics Agency
ISSPRO Wins $250,000 Federal Contract - Targeted News Service
Pfizer, Inc.
Senior doctors attack decision to make people wait 12 weeks for second dose of P... - The Independent UK
United States Department of Veterans Affairs
ALL AMERICAN CONTRACTING SOLUTIONS Wins $24,910 Federal Contract - Targeted News Service
Atlanta Braves, Inc.
SPORTS; RIP to Hammerin' Hank: He had all of the tools - Los Angeles Times
Paths to Furiex Pharmaceuticals Inc.
Potential Connections via
Relationship Science
You
Furiex Pharmaceuticals Inc.
Recent Transactions
Details Hidden

Forest Laboratories, Inc. purchases Furiex Pharmaceuticals Inc.

Details Hidden

purchases Furiex Pharmaceuticals Inc. from Pharmaceutical Product Development LLC

Transaction Advisors
Investment Advisor
Credit Suisse Group AG

Advised onForest Laboratories, Inc. purchases Furiex Pharmaceuticals Inc.

Legal Advisor
Kirkland & Ellis LLP

Advised onForest Laboratories, Inc. purchases Furiex Pharmaceuticals Inc.

Investment Advisor
Merrill Lynch, Pierce, Fenner & Smith, Inc.

Advised onForest Laboratories, Inc. purchases Furiex Pharmaceuticals Inc.

Attorney
Amy E. Davis

Advised onForest Laboratories, Inc. purchases Furiex Pharmaceuticals Inc.

Associate
Benjamin J. Ritzo

Advised onForest Laboratories, Inc. purchases Furiex Pharmaceuticals Inc.

Legal Advisor
Donald R. Reynolds

Advised onForest Laboratories, Inc. purchases Furiex Pharmaceuticals Inc.

Advisors & Consultants
Advisor
Marshall Woodworth

Chief Financial Officer at Braeburn Pharmaceuticals SPRL
Key Stats and Financials As of
Market Capitalization
$1.15B
Total Enterprise Value
Earnings Per Share
Investors
Details Hidden
Fred Eshelman

Chief Executive Officer at Innocrin Pharmaceuticals, Inc.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Furiex Pharmaceuticals Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Furiex Pharmaceuticals Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Furiex Pharmaceuticals Inc..